To: Ken Frazier, CEO of Merck

Merck: Fund studies into the Post Finasteride Syndrome

The Post Finasteride Syndrome is a serious, life-altering condition that occurs in some men after quitting the hairloss, prostate drug Finasteride (Propecia, Proscar). Bringham and Woman's Hospital and Baylor College of Medicine have launched research studies to help find treatments. Merck has an obligation to help.

Why is this important?

Many men have committed suicide due to the severe symptoms of Post-Finasteride Syndrome. Countless others have lost their romantic partners and careers. Thousands of men who take Finasteride are at risk of developing this life-altering condition. The maker of Propecia, Merck, has an ethical responsibility to fund research into the Post Finasteride Syndrome.